-
Recent Posts:
Recent Comments:
Latest PLoG Posts
- Repost: The Pay-for-Delay Tactic in Work In Progress
- How to Find a Fossil in Work In Progress
- Book Review: The Recession Hurt Many People, Now Austerity is Hurting More in Work In Progress
- PLOS ONE welcomes RIAT (Restoring Invisible and Abandoned Trials) Initiative in Work In Progress
- Living science: the importance of science experiences in Brazil in Work In Progress
You may also be interested in:
Click to go to this PLOS Medicine collection
Author: Jessica Wapner
Repost: The Pay-for-Delay Tactic
Category: drug patents, generic drugs
Tagged Actavis, evergreening, Federal Trade Commission, FTC, pay for delay, SCOTUS
Leave a comment
MATH and Tumors
Category: cancer
Tagged cancer, Edmund Mroz, Massachusetts General Hospital, MATH, tumor heterogeneity
1 Comment
Indian Court Rules in Favor of Generic Gleevec
Category: cancer, drug patents
Tagged generic drugs, Gleevec, imatinib mesylate, Novartis
Leave a comment
Jessica Wapner is a freelance writer focused mainly on biomedical issues. Her work is published in Scientific American, The New York Times, Slate, Science, Nature Medicine, and elsewhere. Her first book, The Philadelphia Chromosome is forthcoming from The Experiment in May 2013.